Investment Rating - The report indicates a positive outlook for the home furnishing sector, driven by domestic consumption stimulus and the gradual recovery of retail channels [1]. Core Insights - The report highlights that the domestic consumption stimulus is beginning to show effects, with a notable recovery in retail channels, while export conditions are experiencing marginal declines [1][3]. - The performance of leading companies in the home furnishing sector is improving, particularly in the context of national subsidies and strategic adjustments [1][3]. Summary by Sections 1. Home Furnishing - Domestic sales show signs of recovery with a year-on-year revenue change of -12.44% in Q4 2024 and +1.75% in Q1 2025, while net profit for the same periods changed from -54.11% to +7.07% [13]. - Export performance for the furniture sector saw a cumulative year-on-year increase of +5.8% for 2024 but a decline of -8.0% in Q1 2025, indicating a downward trend in export conditions [13]. - The report anticipates that the domestic market will continue to recover in the short term due to national subsidy policies, while the export market may face ongoing pressures [13]. 1.1 Domestic - Custom Home Furnishing - Retail channels are showing marginal improvements, while bulk channels remain under pressure, with leading companies like Oppein and Sophia experiencing reduced revenue declines in Q1 2025 compared to previous quarters [20]. - The profitability of leading companies is improving, with a focus on cost control and product development, while second and third-tier brands may struggle to maintain performance [26]. - Prepayment and cash flow indicators show improvements for some leading companies, suggesting a gradual recovery in demand [38]. 1.2 Domestic - Soft Home Furnishing - The soft home furnishing sector is under pressure due to real estate downturns and changing consumer spending patterns, but companies like Kuka and Mengbaihe are showing signs of recovery [39]. - Profit margins are improving in Q1 2025 compared to 2024, with notable changes in gross and net profit margins across leading companies [44]. - Prepayment figures for soft home furnishing companies are showing positive growth, indicating a recovery in domestic demand [46]. 1.3 Export Home Furnishing - The overall export climate is declining, with a significant drop in cumulative export value in Q1 2025, reflecting challenges in the international market [51][53]. - Despite the overall decline, leading companies are still managing to perform well, showcasing resilience and strategic advantages [51].

Revenue and Profit - The company achieved total revenue of 6.766 billion yuan in Q1 2025, a year-on-year increase of 1.45% [1] - However, the net profit attributable to shareholders was 32.8145 million yuan, a year-on-year decrease of 16.0%, and the non-recurring net profit was -44.3305 million yuan, a year-on-year decrease of 186.4% [1] Profitability - The company's gross margin was 9.88%, a decrease of 0.05 percentage points year-on-year [2] - The net profit margin was 0.36%, a decrease of 12.56 percentage points year-on-year [2] - Earnings per share were 0.01 yuan, a year-on-year decrease of 33.33% [2] Expense Control - Total selling, administrative, and financial expenses amounted to 606 million yuan, with the three expenses accounting for 8.95% of revenue, a year-on-year decrease of 8.48 percentage points [3] - Despite the decrease in expense ratio, overall expenses remain at a relatively high level [3] Cash Flow and Debt Situation - Operating cash flow per share was 0.05 yuan, a year-on-year decrease of 52.59% [4] - Cash and cash equivalents were 4.757 billion yuan, a year-on-year decrease of 8.25% [4] - Interest-bearing liabilities stood at 27.6 billion yuan, a year-on-year decrease of 12.32%, but the interest-bearing asset-liability ratio reached 50.56%, with a current ratio of only 0.45, indicating short-term debt pressure and cash flow issues [4] Business Model and Capital Return - The company's performance relies heavily on R&D and marketing, but the ROIC last year was only 1.17%, indicating weak capital returns [5] - The net profit margin was -1.69%, suggesting low added value of the company's products or services [5] - Since its listing, the company has raised a total of 7.630 billion yuan and distributed dividends totaling 1.852 billion yuan, resulting in a dividend-to-financing ratio of 0.24 [5] Summary - Overall, the company's performance in Q1 2025 appears weak, particularly in terms of profitability, cash flow, and debt management, indicating significant pressure in these areas [6]

Group 1 - National Integrated Circuit Industry Fund plans to reduce its stake in Jiangbolong by no more than 4,159,815 shares, accounting for 1.00% of the total share capital, between May 27, 2025, and August 26, 2025 [1] - The reduction is due to the fund's operational management needs and will be executed through centralized bidding at market prices [1] - The implementation of this reduction plan will not lead to a change in the company's control or significantly impact its governance structure and ongoing operations [1] Group 2 - Haitai Weiye has received approval from the China Securities Regulatory Commission for its H-share issuance, planning to issue no more than 710.52 million overseas listed ordinary shares [2] - The listing will take place on the main board of the Hong Kong Stock Exchange, but the matter still carries uncertainties [2] Group 3 - Fudan Zhangjiang announced a price reduction of at least 35% for its Doxorubicin Liposome Injection starting May 1, 2025, which is expected to negatively impact sales revenue [3] - The drug generated approximately RMB 210 million in sales for the year 2024, representing 29% of the company's total sales revenue [3] - The price adjustment may lead to a risk of single product loss for the drug in 2025 [3] Group 4 - Xinyuan Technology's director expressed inability to guarantee the authenticity and completeness of the 2024 annual report and related financial documents, citing significant issues identified by the audit firm [4] - The company has received a notice of investigation from the securities regulatory authority, and the audit report issued was unable to express an opinion [4] Group 5 - ST Xinchao announced that its stock will be suspended from trading starting May 6, 2025, due to the inability to disclose the audited 2024 annual report and the 2025 Q1 report within the legal timeframe [5] - If the company fails to disclose the 2024 annual report within two months of the suspension, it will face delisting risk warnings [5] Group 6 - Huakang Clean has pre-won a project worth RMB 167 million [6] - Tongguang Cable has pre-won a procurement project from the State Grid valued at RMB 142 million [6] - Fengmao Co. has increased its investment in a production base in Thailand to RMB 26 million [6] Group 7 - Huaren Pharmaceutical's wholly-owned subsidiary has obtained a medical device registration certificate for wound dressings [7] Group 8 - Major shareholders of Kairun Co. plan to reduce their holdings by no more than 9 million shares [10] - CITIC Securities has completed its reduction plan for China Gold [10] - The reduction plan for Hengfeng Information's director and vice president has been completed [10]

登录新浪财经APP 搜索【信披】查看更多考评等级 在包装业务板块，公司以开放包容的态度，全面拥抱工业具身智能发展新方向，有意愿向产业高新技术 公司提供包装仓储物流方面丰富的业务场景和行业数据积累，共同探索工业具身智能在包装产业落地的 可行性，为客户提供"安全·可靠·柔性·智能"的全方位无人化的仓储物流解决方案。公司致力于持续探索 技术创新与产业升级的可能性，逐步实现从"制造"到"智造"的跨越式发展，更加出色地应对复杂的工作 任务，提升行业核心竞争力。 2、坚持绿色低碳可持续发展道路 在国家"双碳"战略指引下，公司将社会责任融入核心战略，聚焦绿色低碳与可持续发展。推进碳管理体 系认证（EATNS），主动加入科学碳目标倡议（SBTi），设定2020-2030年减碳目标。围绕再生资源循 环利用，绿色能源综合开发，以纸代塑低碳产品的研发，构建全生命周期降碳体系，实现产业绿色转 型。通过碳减排行动和碳交易实现碳资产增值，实现可持续发展。 （三）适时开展股份回购及现金分红，丰富投资者回报形式 1、强化分红管理，增强投资者回报水平 公司高度重视利润分配政策，实施积极稳定的股东回报规划和利润分配政策。在具备利润分配的条件 下 ...

山鹰国际控股股份公司 董事会审计委员会 2024 年度履职报告 2024 年度，山鹰国际控股股份公司（以下简称"公司"）第九届董事会审计 委员会严格按照中国证监会《上市公司治理准则》、上海证券交易所《上市公司 自律监管指引第 1 号——规范运作》以及公司《董事会审计委员会工作细则》等 相关规定，在加强财务报告审计监督、促进内部控制制度建立健全、提高会计信 息质量等方面，勤勉尽职地履行了工作职责。现将 2024 年度工作情况报告如下： 一、董事会审计委员会基本情况 报告期内，公司第九届董事会审计委员会由 3 名委员组成，委员分别为陈 凌云女士、夏莲女士和游知女士，其中独立董事 2 名，会计专业人员的独立董事 1 名，人员构成符合《公司章程》及相关法律法规、规范性文件的规定。 二、董事会审计委员会会议召开情况 2024 年度，审计委员会共召开了 3 次会议，全体委员均亲自出席了会议。 具体情况如下： （一）与外部审计机构沟通会 在公司 2023 年度审计工作中，公司董事会审计委员会严格按照《董事会审 计委员会工作细则》的相关规定，就公司 2023 年度财务报告及内部控制审计时 间安排、人员配置、审计重点及审计要求 ...

| 股票简称：山鹰国际 | | | 股票代码：600567 | 公告编号：临 | 2025-033 | | --- | --- | --- | --- | --- | --- | | 债券简称：鹰 | 19 | 转债 | 债券代码：110063 | | | 山鹰国际控股股份公司 关于公司及控股子公司开展金融衍生品投资业务的 公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 交易目的：公司拟利用金融衍生品进行汇率及利率风险管理，以降低和 防范汇率及利率波动对公司年度经营业绩的影响。 交易品种：美元、欧元、人民币等 交易工具：具体包括远期结售汇、外汇掉期、外汇期权和利率掉期等保 值业务。 交易场所：具有授信额度的商业银行、上海期货交易所、大连商品交易 所 交易金额：2025 年度预计投资净额不超过 1.5 亿美元（含等值其他货币）。 审议程序：该事项已经第九届董事会第二十六次会议和第九届监事会第 八次会议审议通过，尚需提交公司股东大会审议。 特别风险提示：公司开展金融衍生品投资业务，以风险管理及套期保值 为原则 ...

二. 内部控制评价结论 1. 公司于内部控制评价报告基准日，是否存在财务报告内部控制重大缺陷 □是 √否 公司代码：600567 公司简称：山鹰国际 山鹰国际控股股份公司 2024年度内部控制评价报告 山鹰国际控股股份公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要求（以下简称企业内部 控制规范体系），结合本公司（以下简称公司）内部控制制度和评价办法，在内部控制日常监督和专项 监督的基础上，我们对公司2024年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一. 重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其有效性，并如实披露内 部控制评价报告是公司董事会的责任。监事会对董事会建立和实施内部控制进行监督。经理层负责组织 领导企业内部控制的日常运行。公司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存 在任何虚假记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个别及连带法 律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及相关信息真实完整，提 高经营效率和效果，促进实现发展 ...

| | | 股票简称：山鹰国际 股票代码：600567 公告编号：临 2025-034 山鹰国际控股股份公司 关于会计政策变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、本次会计政策变更的概述 （一）会计政策变更的原因及执行时间 2023 年 8 月 21 日,财政部发布《关于印发<企业数据资源相关会计处理暂行 规定>的通知》(财会(2023)11 号)(以下简称《暂行规定》)，该规定自 2024 年 1 月 1 日起施行。 2023 年 10 月 25 日，财政部发布《企业会计准则解释第 17 号》（财会〔2023〕 21 号），规定了"关于流动负债与非流动负债的划分"、"关于供应商融资安 排的披露"、"关于售后租回交易的会计处理"的相关内容，该解释规定自 2024 年 1 月 1 日起施行。 2024 年 12 月 31 日，财政部发布《企业会计准则解释第 18 号》（财会〔2024〕 24 号），规定了"关于浮动收费法下作为基础项目持有的投资性房地产的后续 计量"、"关于不属于单项履约义务 ...

| 股票简称：山鹰国际 | | | 股票代码：600567 | 公告编号：临 | 2025-030 | | --- | --- | --- | --- | --- | --- | | 债券简称：鹰 | 19 | 转债 | 债券代码：110063 | | | 山鹰国际控股股份公司 关于预计2025年度日常关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 是否需要提交股东大会审议：是 公司2025年度预计发生日常关联交易事项没有形成对公司独立性的 影响，公司主要业务也不会因此交易而对关联人形成依赖。 一、日常关联交易基本情况 （一）日常关联交易履行的审议程序 山鹰国际控股股份公司（以下简称"公司"或"本公司"）第九届董事会第 二十六次会议以6票同意、0票反对、0票弃权审议通过了《关于预计2025年度日 常关联交易的议案》，关联董事吴明武先生回避表决。公司2025年日常关联交易 预计金额达到公司最近一期经审计净资产的5%，本议案尚需提交2024年年度股 东大会审议，公司关联股东需对本议案回避表决。 公司 ...

山鹰国际控股股份公司 2024 年度独立董事述职报告 （刘文） 2024 年度，本人作为山鹰国际控股股份公司（以下简称"公司"）的独立 董事，严格按照《公司法》、《上市公司独立董事管理办法》、《公司章程》和 《独立董事制度》等有关规定，在 2024 年的工作中，忠实勤勉地履行职责，及 时了解公司生产经营情况，积极出席公司的董事会、股东大会、董事会专门委 员会，认真审阅各项议案，对公司的生产经营和业务发展提出合理的建议，忠 实履行独立董事的职责和义务，切实维护上市公司股东尤其是中小股东的合法 权益。现将本人 2024 年度履行职责情况报告如下： 一、独立董事的基本情况 本人刘文，男，1965 年出生，中国国籍，林产化工博士，正高级工程师， 博士生导师，国务院政府特殊津贴专家。先后主持和参与国家支撑计划、重点 研发计划、"科技助力经济 2020"重点专项、横向服务、军工配套科研和技改 等多个项目的研究和建设工作。完成的项目曾获轻工总会、黑龙江省、中国烟 草总公司等科技进步奖。曾获中央企业劳动模范，国防科技工业协作配套先进 个人，中国造纸学会蔡伦科技奖。现任中国制浆造纸研究院有限公司总工程师， 中国保利集团有限公司 ...